PI3K inhibition, resulted in PD-L1 downregulation in different cancer types including renal cell carcinoma through HGF/c-Met [36], KRAS- or EGFR-mutated NSCLC [42] and melanoma [32]. The gene discussed is PIK3CA; the disease is cancer.